1. Home
  2. PTIX vs MRIN Comparison

PTIX vs MRIN Comparison

Compare PTIX & MRIN Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • PTIX
  • MRIN
  • Stock Information
  • Founded
  • PTIX 1994
  • MRIN 2006
  • Country
  • PTIX United States
  • MRIN United States
  • Employees
  • PTIX N/A
  • MRIN N/A
  • Industry
  • PTIX Biotechnology: Pharmaceutical Preparations
  • MRIN EDP Services
  • Sector
  • PTIX Health Care
  • MRIN Technology
  • Exchange
  • PTIX Nasdaq
  • MRIN Nasdaq
  • Market Cap
  • PTIX 2.0M
  • MRIN 1.7M
  • IPO Year
  • PTIX 2016
  • MRIN 2013
  • Fundamental
  • Price
  • PTIX $0.22
  • MRIN $0.58
  • Analyst Decision
  • PTIX
  • MRIN
  • Analyst Count
  • PTIX 0
  • MRIN 0
  • Target Price
  • PTIX N/A
  • MRIN N/A
  • AVG Volume (30 Days)
  • PTIX 10.5M
  • MRIN 269.7K
  • Earning Date
  • PTIX 05-14-2025
  • MRIN 05-02-2025
  • Dividend Yield
  • PTIX N/A
  • MRIN N/A
  • EPS Growth
  • PTIX N/A
  • MRIN N/A
  • EPS
  • PTIX N/A
  • MRIN N/A
  • Revenue
  • PTIX N/A
  • MRIN $16,707,999.00
  • Revenue This Year
  • PTIX N/A
  • MRIN N/A
  • Revenue Next Year
  • PTIX N/A
  • MRIN N/A
  • P/E Ratio
  • PTIX N/A
  • MRIN N/A
  • Revenue Growth
  • PTIX N/A
  • MRIN N/A
  • 52 Week Low
  • PTIX $0.18
  • MRIN $0.41
  • 52 Week High
  • PTIX $1.87
  • MRIN $3.53
  • Technical
  • Relative Strength Index (RSI)
  • PTIX 42.85
  • MRIN 33.13
  • Support Level
  • PTIX $0.21
  • MRIN $0.51
  • Resistance Level
  • PTIX $0.25
  • MRIN $0.85
  • Average True Range (ATR)
  • PTIX 0.03
  • MRIN 0.11
  • MACD
  • PTIX -0.01
  • MRIN 0.00
  • Stochastic Oscillator
  • PTIX 9.82
  • MRIN 18.88

About PTIX Protagenic Therapeutics Inc.

Protagenic Therapeutics Inc is a biopharmaceutical company focused on the discovery and development of therapeutics to treat stress-related neuropsychiatric and mood disorders. It provides treatments for mood, anxiety, depression, and neurodegenerative disorders by using peptide-based and brain-active therapeutics. The company's lead compound, PT00114, is a synthetic form of Teneurin Carboxy-terminal Associated Peptide, an endogenous brain signaling peptide that can dampen overactive stress responses. It has also created a portfolio of novel neuropeptides that are in various stages of development and preclinical evaluation for the treatment of mood disorders.

About MRIN Marin Software Incorporated

Marin Software Inc provides a cloud-based digital advertising management solution for search, display, social, and mobile advertising channels to improve financial performance, realize efficiencies and time savings, and improve business decisions. The company's enterprise marketing software platform is offered as an integrated software-as-a-service (SaaS) solution for advertisers and agencies. Its software solution is designed to help its customers measure the effectiveness of their advertising campaigns through its reporting and analytics capabilities; and manage and execute campaigns through its user interface and underlying technology that streamlines and automates functions. All the business activity of the firm is functioned through the geographical regions of The United States.

Share on Social Networks: